DarioHealth to Host First Quarter 2019 Conference Call May 13, 2019

NEW YORK and CAESAREA, Israel, May 7, 2019 /PRNewswire/ — Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its first quarter 2019 results on Monday, May 13, and host a conference call the same morning at 9:00 am EDT.

The Company will discuss its first quarter 2019 operating and financial results and its outlook for 2019.

The call will be hosted by Erez Raphael, Chief Executive Officer, Olivier Jarry, President and Chief Commercial Officer, and Zvi Ben-David, Chief Financial Officer.

The live call can be accessed by dialing 1-844-369-8770 or 1-862-298-0840 (international). Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: https://www.investornetwork.com/event/presentation/48858

Conference Call Details:

Date: Monday, May 13, 2019

Time: 9:00am EDT

Dial-in Number: 1-844-369-8770

International Dial-in Number: 1-862-298-0840

Webcast: https://www.investornetwork.com/event/presentation/48858

Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through May 27, 2019. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 48858. The webcast replay will be available through August 13, 2019.

About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) company revolutionizing the way people manage their health across the chronic condition spectrum. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we developed a novel approach that empowers individuals to adjust their lifestyle in a personalized way. Our Cross Functional Team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Already one of the highest rated diabetes solutions, its user-centric approach is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets.

DarioHealth Corporate Contact:
Joao Mendes-Roter
VP Marketing
joao@mydario.com
+1-347-767-4220

View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-host-first-quarter-2019-conference-call-may-13-2019-300845076.html

SOURCE DarioHealth Corp.

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

32 minutes ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

35 minutes ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago